Pneumococcal Vaccines Market Sets Course to Surpass US$ 13.3 Billion by 2033

Pneumococcal vaccines market size, which offer a powerful defence against illnesses caused by the Streptococcus pneumoniae bacteria, are an essential part of world health. These bacteria are harmful because they can lead to a number of illnesses, including sepsis, meningitis, and pneumonia. They pose a particular risk to small children, the elderly, and those with …

Pneumococcal Vaccines Market is anticipated to valuation of US$ 13.3 Billion by 2033

In its upcoming report titled “Pneumococcal Vaccines Market Throughout the forecast period, a CAGR of 4.1% is expected to be achieved on average by the global market for pneumococcal vaccinations. The market is currently estimated to be worth US$ 8.9 billion in 2023. By 2033, it’s expected that the market for pneumococcal vaccinations would be worth …